Trilogy Capital’s Stryker SYK Stock Holding History

Trilogy Capital’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-132	Closed	-$24K	–	507
2018 Q3	$24K	Hold	132	–	–	﹤0.01%	259
2018 Q2	$22K	Hold	132	–	–	﹤0.01%	242
2018 Q1	$21K	Buy	+132	New	+$21.3K	﹤0.01%	222

Other funds holding SYK

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Trilogy Capital's SYK Position: Q4 2018 in Review

Trilogy Capital sold out of Stryker (SYK) in Q4 2018, closing a stake of 132 shares — an estimated $24K sold.

Trilogy Capital first reported a position in SYK in Q1 2018 and held it in 3 quarters. The position peaked at $24K in Q3 2018. 1,269 funds tracked by Wall St. Rank hold SYK as of Q4 2018.

Trilogy Capital reported no remaining Stryker position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 132 Stryker shares in Q4 2018, an estimated $24K.
Trilogy Capital first reported a position in Stryker in Q1 2018 and held it in 3 quarters.
Trilogy Capital's Stryker position peaked at $24K in Q3 2018.
1,269 funds tracked by Wall St. Rank held Stryker as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.